Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168984349> ?p ?o ?g. }
- W3168984349 endingPage "925" @default.
- W3168984349 startingPage "925" @default.
- W3168984349 abstract "(1) Kinase inhibitors (KI) targeting components of the DNA damage repair pathway are a promising new type of drug. Combining them with ionizing radiation therapy (IR), which is commonly used for treatment of head and neck tumors, could improve tumor control, but could also increase negative side effects on surrounding normal tissue. (2) The effect of KI of the DDR (ATMi: AZD0156; ATRi: VE-822, dual DNA-PKi/mTORi: CC-115) in combination with IR on HPV-positive and HPV-negative HNSCC and healthy skin cells was analyzed. Cell death and cell cycle arrest were determined using flow cytometry. Additionally, clonogenic survival and migration were analyzed. (3) Studied HNSCC cell lines reacted differently to DDRi. An increase in cell death for all of the malignant cells could be observed when combining IR and KI. Healthy fibroblasts were not affected by simultaneous treatment. Migration was partially impaired. Influence on the cell cycle varied between the cell lines and inhibitors; (4) In conclusion, a combination of DDRi with IR could be feasible for patients with HNSCC. Side effects on healthy cells are expected to be limited to normal radiation-induced response. Formation of metastases could be decreased because cell migration is impaired partially. The treatment outcome for HPV-negative tumors tends to be improved by combined treatment." @default.
- W3168984349 created "2021-06-22" @default.
- W3168984349 creator A5014743120 @default.
- W3168984349 creator A5016274811 @default.
- W3168984349 creator A5023036741 @default.
- W3168984349 creator A5027231637 @default.
- W3168984349 creator A5045879421 @default.
- W3168984349 creator A5053999765 @default.
- W3168984349 creator A5058016439 @default.
- W3168984349 creator A5079727934 @default.
- W3168984349 date "2021-06-17" @default.
- W3168984349 modified "2023-10-16" @default.
- W3168984349 title "Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells" @default.
- W3168984349 cites W1566199112 @default.
- W3168984349 cites W184760362 @default.
- W3168984349 cites W1967265143 @default.
- W3168984349 cites W1976385056 @default.
- W3168984349 cites W2015461126 @default.
- W3168984349 cites W2017229935 @default.
- W3168984349 cites W2018116689 @default.
- W3168984349 cites W2023620387 @default.
- W3168984349 cites W2024254896 @default.
- W3168984349 cites W2034411091 @default.
- W3168984349 cites W2061197983 @default.
- W3168984349 cites W2062672151 @default.
- W3168984349 cites W2078789770 @default.
- W3168984349 cites W2120211376 @default.
- W3168984349 cites W2124640278 @default.
- W3168984349 cites W2126614547 @default.
- W3168984349 cites W2130266193 @default.
- W3168984349 cites W2146629016 @default.
- W3168984349 cites W2148098229 @default.
- W3168984349 cites W2154745425 @default.
- W3168984349 cites W2169031119 @default.
- W3168984349 cites W2171279497 @default.
- W3168984349 cites W2334134486 @default.
- W3168984349 cites W2397540382 @default.
- W3168984349 cites W2471011913 @default.
- W3168984349 cites W2567230103 @default.
- W3168984349 cites W2575157150 @default.
- W3168984349 cites W2620329934 @default.
- W3168984349 cites W2725629316 @default.
- W3168984349 cites W2735916077 @default.
- W3168984349 cites W2756095389 @default.
- W3168984349 cites W2762043247 @default.
- W3168984349 cites W2774883837 @default.
- W3168984349 cites W2790093035 @default.
- W3168984349 cites W2805101561 @default.
- W3168984349 cites W2911163118 @default.
- W3168984349 cites W2946847644 @default.
- W3168984349 cites W2957724045 @default.
- W3168984349 cites W2990371825 @default.
- W3168984349 cites W2996267996 @default.
- W3168984349 cites W3005046688 @default.
- W3168984349 cites W3008238566 @default.
- W3168984349 cites W3022486080 @default.
- W3168984349 cites W3029405880 @default.
- W3168984349 cites W3031374116 @default.
- W3168984349 cites W3034290849 @default.
- W3168984349 cites W3034694606 @default.
- W3168984349 cites W3037710615 @default.
- W3168984349 cites W3044999584 @default.
- W3168984349 cites W3050820850 @default.
- W3168984349 cites W3082287410 @default.
- W3168984349 cites W3088066819 @default.
- W3168984349 cites W3088837064 @default.
- W3168984349 cites W3090400266 @default.
- W3168984349 cites W3103103768 @default.
- W3168984349 cites W3107533236 @default.
- W3168984349 cites W3110253998 @default.
- W3168984349 cites W3110663007 @default.
- W3168984349 cites W3123446037 @default.
- W3168984349 cites W4210433744 @default.
- W3168984349 cites W4232711777 @default.
- W3168984349 doi "https://doi.org/10.3390/genes12060925" @default.
- W3168984349 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8235750" @default.
- W3168984349 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34204447" @default.
- W3168984349 hasPublicationYear "2021" @default.
- W3168984349 type Work @default.
- W3168984349 sameAs 3168984349 @default.
- W3168984349 citedByCount "12" @default.
- W3168984349 countsByYear W31689843492022 @default.
- W3168984349 countsByYear W31689843492023 @default.
- W3168984349 crossrefType "journal-article" @default.
- W3168984349 hasAuthorship W3168984349A5014743120 @default.
- W3168984349 hasAuthorship W3168984349A5016274811 @default.
- W3168984349 hasAuthorship W3168984349A5023036741 @default.
- W3168984349 hasAuthorship W3168984349A5027231637 @default.
- W3168984349 hasAuthorship W3168984349A5045879421 @default.
- W3168984349 hasAuthorship W3168984349A5053999765 @default.
- W3168984349 hasAuthorship W3168984349A5058016439 @default.
- W3168984349 hasAuthorship W3168984349A5079727934 @default.
- W3168984349 hasBestOaLocation W31689843491 @default.
- W3168984349 hasConcept C111337013 @default.
- W3168984349 hasConcept C117262875 @default.
- W3168984349 hasConcept C121332964 @default.
- W3168984349 hasConcept C143425029 @default.
- W3168984349 hasConcept C1491633281 @default.